Description
CJC-1295 (No DAC) is a synthetic peptide analog of Growth Hormone Releasing Hormone (GHRH) designed to stimulate the pituitary gland to increase growth hormone (GH) secretion. Unlike the CJC-1295 with DAC (Drug Affinity Complex), the No DAC version has a shorter half-life, allowing for more precise, pulsatile GH release in research protocols.
How It Works
-
Binds to GHRH receptors in the pituitary, triggering the natural release of growth hormone.
-
Stimulates pulsatile GH release, mimicking physiological patterns without prolonged exposure.
-
Often used in combination with GHRPs like Ipamorelin, Tesamorelin, or Semorelin to amplify GH secretion and optimize regenerative effects.
Potential Research Benefits
-
Supports Lean Muscle Growth & Recovery – Pulsatile GH release may promote protein synthesis, muscle repair, and tissue regeneration.
-
Fat Metabolism & Body Composition – GH pathways support fat oxidation, which may help improve body composition in research models.
-
Bone & Connective Tissue Health – May enhance bone density and connective tissue strength by stimulating GH-dependent anabolic processes.
-
Anti-Aging & Cellular Regeneration – GH release can influence skin elasticity, energy metabolism, and overall tissue recovery.
-
Selective, Controlled GH Stimulation – Short half-life allows researchers to study specific GH pulses without prolonged systemic effects.
Disclaimer:
For research use only.
Reviews
There are no reviews yet.